Cargando…
Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
SIMPLE SUMMARY: The initial tumour burden is a strong and well-known prognostic factor in oncology. A systematic review was performed to examine if and how the initial tumour burden is reported in phase III clinical trials in the most frequent and deadly cancers. Seventy trials were selected, which...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264965/ https://www.ncbi.nlm.nih.gov/pubmed/35805034 http://dx.doi.org/10.3390/cancers14133262 |